Cargando…
A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex—An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface
In-crystal fragment screening is a powerful tool to chemically probe the surfaces used by proteins to interact, and identify the chemical space worth exploring to design protein-protein inhibitors. A crucial prerequisite is the identification of a crystal form where the target area is exposed and ac...
Autores principales: | Nichols, Charlie, Ng, Joseph, Keshu, Annika, Fraternali, Franca, De Nicola, Gian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768231/ https://www.ncbi.nlm.nih.gov/pubmed/33381049 http://dx.doi.org/10.3389/fphar.2020.615211 |
Ejemplares similares
-
Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022) -
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020) -
Electrostatic Interactions Explain the Higher Binding
Affinity of the CR3022 Antibody
for SARS-CoV-2 than the 4A8 Antibody
por: Nguyen, Hung, et al.
Publicado: (2021) -
Development of a Single-Chain Variable Fragment of CR3022 for a Plasmonic-Based Biosensor Targeting the SARS-CoV-2 Spike Protein
por: Tohari, Taufik Ramdani, et al.
Publicado: (2022) -
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
por: Atyeo, Caroline, et al.
Publicado: (2021)